Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact
Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: DCN

Gene summary for DCN

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

DCN

Gene ID

1634

Gene namedecorin
Gene AliasCSCD
Cytomap12q21.33
Gene Typeprotein-coding
GO ID

GO:0000003

UniProtAcc

P07585


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
1634DCNCA_HPV_3HumanCervixCC4.52e-357.84e-010.0414
1634DCNN_HPV_2HumanCervixN_HPV1.22e-145.18e-01-0.0131
1634DCNT1HumanCervixCC2.52e-02-1.67e-010.0918
1634DCNAEH-subject1HumanEndometriumAEH1.52e-43-9.66e-01-0.3059
1634DCNAEH-subject2HumanEndometriumAEH7.87e-43-1.11e+00-0.2525
1634DCNAEH-subject3HumanEndometriumAEH5.65e-46-1.10e+00-0.2576
1634DCNAEH-subject4HumanEndometriumAEH1.13e-08-6.38e-01-0.2657
1634DCNAEH-subject5HumanEndometriumAEH2.31e-52-1.14e+00-0.2953
1634DCNEEC-subject1HumanEndometriumEEC4.30e-54-1.15e+00-0.2682
1634DCNEEC-subject2HumanEndometriumEEC2.14e-57-1.18e+00-0.2607
1634DCNEEC-subject3HumanEndometriumEEC4.89e-42-9.52e-01-0.2525
1634DCNEEC-subject4HumanEndometriumEEC5.83e-35-9.00e-01-0.2571
1634DCNEEC-subject5HumanEndometriumEEC1.09e-49-1.09e+00-0.249
1634DCNGSM5276935HumanEndometriumEEC1.70e-54-1.14e+00-0.123
1634DCNGSM5276937HumanEndometriumEEC5.72e-14-6.91e-01-0.0897
1634DCNGSM6177620_NYU_UCEC1_lib1_lib1HumanEndometriumEEC2.21e-44-1.19e+00-0.1869
1634DCNGSM6177620_NYU_UCEC1_lib2_lib2HumanEndometriumEEC4.75e-43-1.20e+00-0.1875
1634DCNGSM6177620_NYU_UCEC1_lib3_lib3HumanEndometriumEEC2.73e-49-1.20e+00-0.1883
1634DCNGSM6177621_NYU_UCEC2_lib1_lib1HumanEndometriumEEC2.76e-62-1.19e+00-0.1934
1634DCNGSM6177622_NYU_UCEC3_lib1_lib1HumanEndometriumEEC2.62e-65-1.20e+00-0.1917
Page: 1 2 3 4 5 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
CervixThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.CC: Cervix cancer
HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions
N_HPV: HPV-infected normal cervix
EndometriumThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AEH: Atypical endometrial hyperplasia
EEC: Endometrioid Cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
SkinThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AK: Actinic keratosis
cSCC: Cutaneous squamous cell carcinoma
SCCIS:squamous cell carcinoma in situ
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:001063120EsophagusESCCepithelial cell migration187/8552357/187236.05e-032.23e-02187
GO:009013220EsophagusESCCepithelium migration188/8552360/187236.96e-032.54e-02188
GO:00016559EsophagusESCCurogenital system development177/8552338/187237.51e-032.69e-02177
GO:009013020EsophagusESCCtissue migration190/8552365/187237.91e-032.82e-02190
GO:001470615EsophagusESCCstriated muscle tissue development197/8552384/187231.46e-024.74e-02197
GO:000989620Oral cavityOSCCpositive regulation of catabolic process307/7305492/187232.29e-267.64e-24307
GO:003133120Oral cavityOSCCpositive regulation of cellular catabolic process273/7305427/187236.39e-262.02e-23273
GO:001623610Oral cavityOSCCmacroautophagy192/7305291/187237.01e-211.14e-18192
GO:001050610Oral cavityOSCCregulation of autophagy198/7305317/187231.63e-171.51e-15198
GO:004206020Oral cavityOSCCwound healing237/7305422/187234.51e-132.18e-11237
GO:00162417Oral cavityOSCCregulation of macroautophagy96/7305141/187232.33e-129.75e-1196
GO:00482852Oral cavityOSCCorganelle fission265/7305488/187233.22e-121.27e-10265
GO:001082117Oral cavityOSCCregulation of mitochondrion organization97/7305144/187234.78e-121.83e-1097
GO:000756818Oral cavityOSCCaging194/7305339/187236.18e-122.33e-10194
GO:00108227Oral cavityOSCCpositive regulation of mitochondrion organization53/730574/187231.26e-082.55e-0753
GO:000189017Oral cavityOSCCplacenta development87/7305144/187231.54e-072.56e-0687
GO:00105087Oral cavityOSCCpositive regulation of autophagy77/7305124/187231.59e-072.61e-0677
GO:006145817Oral cavityOSCCreproductive system development217/7305427/187233.75e-075.63e-06217
GO:003249617Oral cavityOSCCresponse to lipopolysaccharide178/7305343/187237.27e-071.03e-05178
GO:004860816Oral cavityOSCCreproductive structure development214/7305424/187238.58e-071.18e-05214
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
hsa0520516CervixCCProteoglycans in cancer60/1267205/84659.13e-081.18e-067.00e-0760
hsa0520517CervixCCProteoglycans in cancer60/1267205/84659.13e-081.18e-067.00e-0760
hsa0520518EndometriumAEHProteoglycans in cancer53/1197205/84655.43e-066.53e-054.78e-0553
hsa043504EndometriumAEHTGF-beta signaling pathway26/1197108/84653.82e-032.18e-021.59e-0226
hsa0520519EndometriumAEHProteoglycans in cancer53/1197205/84655.43e-066.53e-054.78e-0553
hsa0435011EndometriumAEHTGF-beta signaling pathway26/1197108/84653.82e-032.18e-021.59e-0226
hsa0520524EndometriumEECProteoglycans in cancer52/1237205/84653.01e-053.19e-042.38e-0452
hsa043502EndometriumEECTGF-beta signaling pathway26/1237108/84655.95e-033.12e-022.33e-0226
hsa0520534EndometriumEECProteoglycans in cancer52/1237205/84653.01e-053.19e-042.38e-0452
hsa043503EndometriumEECTGF-beta signaling pathway26/1237108/84655.95e-033.12e-022.33e-0226
hsa0520529EsophagusESCCProteoglycans in cancer138/4205205/84651.79e-071.40e-067.15e-07138
hsa043507EsophagusESCCTGF-beta signaling pathway69/4205108/84651.92e-035.54e-032.84e-0369
hsa0520537EsophagusESCCProteoglycans in cancer138/4205205/84651.79e-071.40e-067.15e-07138
hsa0435014EsophagusESCCTGF-beta signaling pathway69/4205108/84651.92e-035.54e-032.84e-0369
hsa0520526Oral cavityOSCCProteoglycans in cancer128/3704205/84654.00e-083.12e-071.59e-07128
hsa043506Oral cavityOSCCTGF-beta signaling pathway60/3704108/84658.66e-031.97e-021.00e-0260
hsa05205111Oral cavityOSCCProteoglycans in cancer128/3704205/84654.00e-083.12e-071.59e-07128
hsa0435013Oral cavityOSCCTGF-beta signaling pathway60/3704108/84658.66e-031.97e-021.00e-0260
hsa0520527Oral cavityLPProteoglycans in cancer77/2418205/84653.01e-031.29e-028.35e-0377
hsa0520536Oral cavityLPProteoglycans in cancer77/2418205/84653.01e-031.29e-028.35e-0377
Page: 1 2 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
DCNSNVMissense_Mutationc.912N>Gp.Ile304Metp.I304MP07585protein_codingdeleterious(0)probably_damaging(0.999)TCGA-AC-A23H-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownPD
DCNSNVMissense_Mutationrs777073492c.569N>Ap.Gly190Glup.G190EP07585protein_codingtolerated(0.06)probably_damaging(1)TCGA-AN-A046-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
DCNSNVMissense_Mutationc.368N>Cp.Gly123Alap.G123AP07585protein_codingtolerated(0.15)benign(0.003)TCGA-D8-A1J8-01Breastbreast invasive carcinomaFemale>=65I/IIHormone TherapynolvadexSD
DCNinsertionNonsense_Mutationnovelc.404_405insGTGCTTAACTACAGATATTTTGAGATACCp.Tyr135Terp.Y135*P07585protein_codingTCGA-A8-A08P-01Breastbreast invasive carcinomaFemale>=65III/IVChemotherapy5-fluorouracilCR
DCNinsertionFrame_Shift_Insnovelc.390_391insGATATTATAAGGAATAGGAGACTATGTCCAATCACGTTCTGTCAGAp.Leu131AspfsTer44p.L131Dfs*44P07585protein_codingTCGA-A8-A09K-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
DCNSNVMissense_Mutationnovelc.849N>Cp.Arg283Serp.R283SP07585protein_codingtolerated(0.31)benign(0.001)TCGA-AA-3966-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
DCNSNVMissense_Mutationc.425N>Cp.Lys142Thrp.K142TP07585protein_codingtolerated(1)benign(0.011)TCGA-AD-6548-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
DCNSNVMissense_Mutationnovelc.449N>Cp.Lys150Thrp.K150TP07585protein_codingtolerated(0.07)possibly_damaging(0.467)TCGA-CA-6717-01Colorectumcolon adenocarcinomaMale<65I/IIChemotherapyoxaliplatinCR
DCNSNVMissense_Mutationc.283N>Ap.Glu95Lysp.E95KP07585protein_codingtolerated(0.09)probably_damaging(0.995)TCGA-CA-6717-01Colorectumcolon adenocarcinomaMale<65I/IIChemotherapyoxaliplatinCR
DCNSNVMissense_Mutationc.563N>Tp.Ser188Ilep.S188IP07585protein_codingdeleterious(0)probably_damaging(0.921)TCGA-CK-6746-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
Page: 1 2 3 4 5 6 7 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
1634DCNDRUGGABLE GENOMEIFN12707320
1634DCNDRUGGABLE GENOMEHSP709292805
1634DCNDRUGGABLE GENOMEASCORBIC ACID7944410
1634DCNDRUGGABLE GENOMERAPAMYCINSIROLIMUS17200203
Page: 1